• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL TRIFECTA¿ GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-19A
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/05/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on an unknown date, a 19mm trifecta gt valve was implanted.On an unknown date, the valve was explanted due to unknown reasons.The patient was reported to be stable and recovering.
 
Additional Manufacturer Narrative
Explant of trifecta valve due to an unknown reason was reported.The investigation found calcifications on all leaflets.There was fibrous thickening on all leaflets and circumferential fibrous pannus ingrowth on the inflow and outflow surfaces of leaflet 2.Leaflets 1 and 2 were torn, tears were associated with calcifications.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.While the exact reason for valve explant remains unknown, calcifications and pannus ingrowth could lead to a number of potential issues with valve functionality.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA¿ GT VALVE
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key21479644
Report Number2135147-2025-00979
Device Sequence Number3956740
Product Code LWR
UDI-Device Identifier05415067018205
UDI-Public(01)05415067018205(17)211112
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P100029
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/12/2021
Device Model NumberTFGT-19A
Device Catalogue NumberTFGT-19A
Device Lot Number6234839
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/05/2025
Supplement Date Received by Manufacturer04/07/2025
Initial Report FDA Received Date02/27/2025
Supplement Report FDA Received Date04/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/13/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-